29.
[]. Ana Martinez, et al. SAR and D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase inhibitors. J Med Chem. 25 Nov 7;48(2):7-2.
[2]. Johayra Simithy, et al. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition. Anal Chem. 25 Feb 7;87(4):229-6.
[]. Kelsey N Schafer, et al. Structural determinants of Tau aggregation inhibitor potency. J Biol Chem. 2 Nov 8;288(45):2599-26.
[4]. Liping Zhang, et al. Inhibitor selectivity between aldo-keto reductase superfamily members AKRB and AKRB: role of Trp2 (Trp). FEBS Lett. 2 Nov 5;587(22):68-6.
[5]. Mohammad Hosein Farzaei, et al. Biochemical and histopathological evidence on the beneficial effects of Tragopogon graminifolius in TNBS-induced colitis. Pharm Biol. 25 Mar;5():429-6.
H2-H9
P264-P27-P28-P-P5
GHS7